 The purpose of this study is to determine if recipients of non-myeloablative ex-vivo T-cell depleted peripheral blood PBSC stem cell transplantation using a mismatched related donor will have less severe graft versus host disease GVHD, transplant related mortality, and less graft failure compared to alternative haploidentical stem cell transplantation. 